BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12953945)

  • 1. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial.
    Wullt M; Hagslätt ML; Odenholt I
    Scand J Infect Dis; 2003; 35(6-7):365-7. PubMed ID: 12953945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea.
    Wullt M; Johansson Hagslätt ML; Odenholt I; Berggren A
    Dig Dis Sci; 2007 Sep; 52(9):2082-6. PubMed ID: 17420953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial.
    Hickson M; D'Souza AL; Muthu N; Rogers TR; Want S; Rajkumar C; Bulpitt CJ
    BMJ; 2007 Jul; 335(7610):80. PubMed ID: 17604300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.
    Allen SJ; Wareham K; Wang D; Bradley C; Hutchings H; Harris W; Dhar A; Brown H; Foden A; Gravenor MB; Mack D
    Lancet; 2013 Oct; 382(9900):1249-57. PubMed ID: 23932219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics.
    Lönnermark E; Friman V; Lappas G; Sandberg T; Berggren A; Adlerberth I
    J Clin Gastroenterol; 2010 Feb; 44(2):106-12. PubMed ID: 19727002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial.
    Mattila E; Anttila VJ; Broas M; Marttila H; Poukka P; Kuusisto K; Pusa L; Sammalkorpi K; Dabek J; Koivurova OP; Vähätalo M; Moilanen V; Widenius T
    Scand J Infect Dis; 2008; 40(9):702-8. PubMed ID: 19086244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Surawicz CM; McFarland LV; Greenberg RN; Rubin M; Fekety R; Mulligan ME; Garcia RJ; Brandmarker S; Bowen K; Borjal D; Elmer GW
    Clin Infect Dis; 2000 Oct; 31(4):1012-7. PubMed ID: 11049785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon.
    Goossens DA; Jonkers DM; Russel MG; Stobberingh EE; Stockbrügger RW
    Aliment Pharmacol Ther; 2006 Jan; 23(2):255-63. PubMed ID: 16393305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of recurrent Clostridium difficile-associated disease.
    Surawicz CM
    Nat Clin Pract Gastroenterol Hepatol; 2004 Nov; 1(1):32-8. PubMed ID: 16265042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea.
    Wullt M; Odenholt I
    J Antimicrob Chemother; 2004 Jul; 54(1):211-6. PubMed ID: 15163651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.
    McFarland LV; Surawicz CM; Greenberg RN; Fekety R; Elmer GW; Moyer KA; Melcher SA; Bowen KE; Cox JL; Noorani Z
    JAMA; 1994 Jun 22-29; 271(24):1913-8. PubMed ID: 8201735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics in the prevention and treatment of gastrointestinal infections.
    Huebner ES; Surawicz CM
    Gastroenterol Clin North Am; 2006 Jun; 35(2):355-65. PubMed ID: 16880070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a randomized, double-blind, and placebo-controlled trial.
    Kaźmierczak-Siedlecka K; Folwarski M; Skonieczna-Żydecka K; Ruszkowski J; Makarewicz W
    Nutr J; 2020 Sep; 19(1):98. PubMed ID: 32917221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects.
    Goossens D; Jonkers D; Russel M; Stobberingh E; Van Den Bogaard A; StockbrUgger R
    Aliment Pharmacol Ther; 2003 Sep; 18(5):495-505. PubMed ID: 12950422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clostridium-difficile-associated diarrhea].
    Bujanda L; Cosme A
    Gastroenterol Hepatol; 2009 Jan; 32(1):48-56. PubMed ID: 19174100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.
    McFarland LV
    Anaerobe; 2009 Dec; 15(6):274-80. PubMed ID: 19825425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.